US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
US20100035756A1
(en)
*
|
2006-07-12 |
2010-02-11 |
Syngenta Limited |
Triazolophyridine derivatives as herbicides
|
JP5336375B2
(ja)
|
2006-08-30 |
2013-11-06 |
セルゾーム リミテッド |
キナーゼ阻害剤としてのトリアゾール誘導体
|
EP1894931A1
(en)
*
|
2006-08-30 |
2008-03-05 |
Cellzome Ag |
Triazole derivatives as kinase inhibitors
|
CA2670636A1
(en)
*
|
2006-11-27 |
2008-06-05 |
H. Lundbeck A/S |
Heteroaryl amide derivatives
|
MX2009005603A
(es)
|
2006-12-04 |
2009-06-08 |
Astrazeneca Ab |
Compuestos de urea policiclicos antibacterianos.
|
KR20090130109A
(ko)
|
2007-04-10 |
2009-12-17 |
하. 룬트벡 아크티에 셀스카브 |
P2x7 길항제로서의 헤테로아릴 아미드 유사체
|
WO2008125111A1
(en)
*
|
2007-04-16 |
2008-10-23 |
Leo Pharma A/S |
Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
|
MX2010000716A
(es)
*
|
2007-07-18 |
2010-03-26 |
Novartis Ag |
Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
MX2010005700A
(es)
|
2007-11-27 |
2010-06-11 |
Cellzome Ltd |
Amino triazoles como inhibidores pi3k.
|
US20110105457A1
(en)
*
|
2008-04-18 |
2011-05-05 |
Shionogi & Co., Ltd. |
Heterocyclic compound having inhibitory activity on pi3k
|
PE20110063A1
(es)
*
|
2008-06-20 |
2011-02-16 |
Genentech Inc |
DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK
|
CA2727036C
(en)
|
2008-06-20 |
2017-03-21 |
Genentech, Inc. |
Triazolopyridine jak inhibitor compounds and methods
|
JPWO2009157423A1
(ja)
|
2008-06-24 |
2011-12-15 |
財団法人乙卯研究所 |
縮合環を有するオキサゾリジノン誘導体
|
WO2010007100A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Cellzome Ltd |
7-substituted amino triazoles as pi3k inhibitors
|
WO2010010187A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
WO2010010189A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
WO2010010184A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
[1, 2, 4] triazolo [1, 5-a] pyridines as jak inhibitors
|
TWI453207B
(zh)
|
2008-09-08 |
2014-09-21 |
Signal Pharm Llc |
胺基三唑并吡啶,其組合物及使用其之治療方法
|
WO2010057877A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Cellzome Limited |
7-pyridinyl- or phenyl- substituted triazolo [1, 5 -a] pyridines as pi3k inhibitors
|
WO2010092015A1
(en)
|
2009-02-10 |
2010-08-19 |
Cellzome Limited |
Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
|
CA2763900A1
(en)
|
2009-06-05 |
2010-12-09 |
Cephalon, Inc. |
Preparation and uses of 1,2,4-triazolo [1,5a] pyridine derivatives
|
JO3030B1
(ar)
|
2009-06-26 |
2016-09-05 |
Galapagos Nv |
مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
|
TWI462920B
(zh)
|
2009-06-26 |
2014-12-01 |
葛萊伯格有限公司 |
用於治療退化性及發炎疾病之新穎化合物
|
EP2343297A1
(en)
|
2009-11-30 |
2011-07-13 |
Bayer Schering Pharma AG |
Triazolopyridines
|
EP2343294A1
(en)
|
2009-11-30 |
2011-07-13 |
Bayer Schering Pharma AG |
Substituted triazolopyridines
|
BR112012024705A2
(pt)
|
2010-03-31 |
2016-06-07 |
Actelion Pharmaceuticals Ltd |
derivados antibacterianos de isoquinolin-3-ilureia
|
WO2012068096A2
(en)
|
2010-11-15 |
2012-05-24 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
AR088729A1
(es)
|
2011-03-29 |
2014-07-02 |
Actelion Pharmaceuticals Ltd |
Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica
|
EP2825540B1
(en)
|
2012-03-14 |
2016-09-14 |
Bayer Intellectual Property GmbH |
Substituted imidazopyridazines
|
US10450193B2
(en)
*
|
2012-03-30 |
2019-10-22 |
Monsanto Technology Llc |
Alcohol reformer for reforming alcohol to mixture of gas including hydrogen
|
PE20150354A1
(es)
*
|
2012-07-10 |
2015-03-21 |
Bayer Pharma AG |
Metodos para preparar triazolopiridinas sustituidas
|
EP2872509B1
(en)
|
2012-07-12 |
2016-09-14 |
Chiesi Farmaceutici S.p.A. |
Inhibition of enzymes
|
US9586958B2
(en)
|
2013-06-11 |
2017-03-07 |
Bayer Pharma Aktiengesellschaft |
Prodrug derivatives of substituted triazolopyridines
|
GB201402071D0
(en)
|
2014-02-07 |
2014-03-26 |
Galapagos Nv |
Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
|
GB201402070D0
(en)
|
2014-02-07 |
2014-03-26 |
Galapagos Nv |
Pharmaceutical compositions for the treatment of inflammatory disorders
|
CN106488915B
(zh)
|
2014-02-13 |
2020-10-02 |
因赛特公司 |
作为lsd1抑制剂的环丙胺
|
US9527835B2
(en)
|
2014-02-13 |
2016-12-27 |
Incyte Corporation |
Cyclopropylamines as LSD1 inhibitors
|
EP3392244A1
(en)
|
2014-02-13 |
2018-10-24 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
EP3626713B1
(en)
|
2014-02-13 |
2021-09-29 |
Incyte Corporation |
Cyclopropylamines for use as lsd1 inhibitors
|
US9695168B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
US9695167B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
|
AU2016243939B2
(en)
|
2015-04-03 |
2020-09-03 |
Incyte Holdings Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
CN105175411B
(zh)
*
|
2015-05-06 |
2017-08-15 |
西安交通大学 |
一种脲类化合物及其盐类化合物的合成方法和应用
|
EA035534B1
(ru)
|
2015-08-12 |
2020-06-30 |
Инсайт Корпорейшн |
Соли ингибитора lsd1
|
SG11201809299QA
(en)
|
2016-04-22 |
2018-11-29 |
Incyte Corp |
Formulations of an lsd1 inhibitor
|
AU2018239711A1
(en)
|
2017-03-24 |
2019-11-07 |
Taisho Pharmaceutical Co., Ltd. |
2(1h)-quinolinone derivative
|
WO2020047198A1
(en)
|
2018-08-31 |
2020-03-05 |
Incyte Corporation |
Salts of an lsd1 inhibitor and processes for preparing the same
|
AU2020246313B2
(en)
*
|
2019-03-22 |
2022-08-04 |
Genfleet Therapeutics (Shanghai) Inc. |
Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereof
|